Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 6, 2008, Pages 521-529

  Engels, Knut ^a   Jungnickel, Berit ^b   Tobollik, Stephanie ^b   Hansmann, Martin Leo ^a   Kriener, Susanne ^a   Willenbrock, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Activation induced cytidine deaminase; Bone marrow; Malignant lymphoma

Indexed keywords

CYTIDINE DEAMINASE; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); TUMOR MARKER;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; BONE MARROW BIOPSY; BURKITT LYMPHOMA; CANCER INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HAIRY CELL LEUKEMIA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH FOLLICLE; LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NODAL MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; T LYMPHOCYTE; CANCER INVASION; CELL DIFFERENTIATION; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; PSEUDOLYMPHOMA;

B-LYMPHOCYTES; BONE MARROW; CELL DIFFERENTIATION; CYTIDINE DEAMINASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOHISTOCHEMISTRY; LEUKEMIC INFILTRATION; LYMPHOMA; PROGNOSIS; PSEUDOLYMPHOMA; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 67650308916     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181758ce5     Document Type: Article

References (38)

1. Berek C, Berger A, Apel M. Maturation of the immune response in germinal centers. Cell. 1991;67:1121-1129. (Pubitemid 121001525)
2. Jacob J, Kelsoe G, Rajewsky K, et al. Intraclonal generation of antibody mutants in germinal centres. Nature. 1991;354: 389-392. (Pubitemid 21896846)
3. Kü ppers R, Zhao M, Hansmann ML, et al. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993;12: 4955-4967.
4. MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12: 117-139.
5. Pascual V, Liu YJ, Magalski A, et al. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180:329-339. (Pubitemid 24181081)
6. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381:751-758. (Pubitemid 26243107)
7. Kü ppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20:5580-5594.
8. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412:341-346. (Pubitemid 32691848)
9. Kü ppers R, Klein U, Hansmann ML, et al. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
10. Oeschger S, Brä uninger A, Kü ppers R, et al. Tumor cell dissemination in follicular lymphoma. Blood. 2002;99:2192-2198.
11. Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102:553-563.
12. Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102:565-575.
13. Cattoretti G, Buttner M, Shaknovich R, et al. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood. 2006;107:3967-3975. (Pubitemid 43726803)
14. Kü ppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251-262.
15. Basso K, Liso A, Tiacci E, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199:59-68. (Pubitemid 38076478)
16. Bödör C, Bognar A, Reiniger L, et al. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol. 2005;129:373-376.
17. Forconi F, Sahota SS, Raspadori D, et al. Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. Blood. 2004;104:3312-3317. (Pubitemid 39507151)
18. Greeve J, Philipsen A, Krause K, et al. Expression of activationinduced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 2003;101:3574-3580. (Pubitemid 36857944)
19. Greiner A, Tobollik S, Buettner M, et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte- predominant and classical Hodgkin lymphoma. J Pathol. 2005;205:541-547. (Pubitemid 40514826)
20. Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood. 2004;104: 3318-3325. (Pubitemid 39507152)
21. Smit LA, Bende RJ, Aten J, et al. Expression of activationinduced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 2003;63: 3894-3898. (Pubitemid 36917901)
22. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: Kleihues P, Sobin LH, eds. WHO Classification of Tumours. Lyon, France: IARC Press; 2001.
23. Schaefer HE. Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis. Pathologe. 1995;16:11-27.
24. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847. (Pubitemid 28331029)
25. Willenbrock K, Jungnickel B, Hansmann ML, et al. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase. Eur J Immunol. 2005;35:3002-3007. (Pubitemid 41555096)
26. Canioni D, Brice P, Lepage E, et al. Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires. Br J Haematol. 2004;126:364-371. (Pubitemid 39005716)
27. Babbage G, Garand R, Robillard N, et al. Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood. 2004;103:2795-2798. (Pubitemid 38393039)
28. Degan M, Bomben R, Bo MD, et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol. 2004;126:29-42. (Pubitemid 38859479)
29. Heintel D, Kroemer E, Kienle D, et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia. 2004;18:756-762. (Pubitemid 38500194)
30. McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood. 2003;101:4903-4908. (Pubitemid 36857752)
31. Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood. 2003;101: 4029-4032. (Pubitemid 36857882)
32. Oppezzo P, Dumas G, Lalanne AI, et al. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood. 2005;105:2495-2503. (Pubitemid 40387051)
33. Albesiano E, Messmer BT, Damle RN, et al. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood. 2003;102:3333-3339. (Pubitemid 37314775)
34. Roers A, Hansmann ML, Rajewsky K, et al. Single-cell PCR analysis of T helper cells in human lymph node germinal centers. Am J Pathol. 2000;156:1067-1071. (Pubitemid 30626964)
35. Mottok A, Hansmann ML, Brä uninger A. Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma. J Clin Pathol. 2005;58:1002-1004. (Pubitemid 41265294)
36. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159-2169. (Pubitemid 39507628)
37. Ghia P, Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res. 2000;79:157-173. (Pubitemid 30228123)
38. Ghia P, Granziero L, Chilosi M, et al. Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol. 2002;12: 149-155. (Pubitemid 34680744)